뇌진탕 시장 : 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Concussion Market was valued at USD 7.5 billion in 2024 and is expected to experience robust growth at a CAGR of 4.8% from 2025 to 2034. This growth is primarily driven by the rising incidence of traumatic brain injuries, growing awareness about concussion management, and favorable regulatory policies that support advancements in diagnostic and treatment solutions.

In terms of market segments, the concussion market is divided into assessment and diagnostic tools, as well as treatment solutions. The assessment and diagnostic tools segment was the dominant category in 2024, generating USD 5.3 billion. This segment's dominance can be attributed to the rapid advancements in diagnostic technologies, including magnetic resonance imaging (MRI) and computed tomography (CT) scans, which have significantly improved concussion diagnosis accuracy. In addition, innovations such as functional neuroimaging and diffusion tensor imaging (DTI) are pushing the boundaries of diagnostic capabilities, allowing for the detection of even subtle brain injuries that traditional methods may miss.

The market is also segmented by end-use, which includes hospitals, diagnostic centers, and other healthcare facilities. Hospitals were the leading segment in 2024 and are expected to reach USD 7.7 billion by 2034. Equipped with state-of-the-art diagnostic technologies, hospitals are the preferred choice for concussion evaluation and treatment. The presence of multidisciplinary healthcare teams, including neurologists, emergency specialists, and rehabilitation experts, ensures comprehensive care, leading to better patient outcomes. This comprehensive approach plays a vital role in managing concussion cases effectively.

In the U.S., the concussion market accounted for USD 3.2 billion in 2024 and is projected to grow at a CAGR of 4.2% throughout the forecast period. The U.S. benefits from a well-established healthcare infrastructure, continuous innovations in medical technologies, and stringent safety regulations, particularly in sports, which emphasize the need for reliable concussion assessment tools. These factors contribute to a growing demand for advanced concussion diagnostics. Additionally, substantial investments in research and the rising adoption of portable diagnostic devices are expected to further fuel market growth in the region.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising traumatic brain injuries
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Growing awareness
    • 3.2.1.4 Supportive regulatory landscape
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced diagnostics tools
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Technology landscape
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Assessment and diagnostic tools
  • 5.2.1 CT
  • 5.2.2 MRI
  • 5.2.3 EEG
  • 5.2.4 Other assessment and diagnostic tools
• 5.3 Treatment

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Diagnostic centers
• 6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Advanced Brain Monitoring
• 8.2 BIOMÉRIEUX
• 8.3 BrainScope
• 8.4 Compumedics
• 8.5 GE Healthcare
• 8.6 Healius
• 8.7 INTEGRA LIFESCIENCES
• 8.8 Koninklijke Philips N.V.
• 8.9 NanoDx
• 8.10 NIHON KOHDEN
• 8.11 Oculogica
• 8.12 Siemens Healthineers